Neoplasms Metastasis Completed Phase 2 Trials for Erlotinib (DB00530)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00116506Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal CancerTreatment
NCT00123851Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerTreatment
NCT00125021Tarceva and Capecitabine for Pancreatic CancerTreatment